openPR Logo
Press release

ReachOwl Revolutionizes Facebook and Instagram Outreach with Cloud-Based Automation

03-25-2025 02:28 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

ReachOwl Revolutionizes Facebook and Instagram Outreach with

LONDON, UK - March 24th, 2025 - ReachOwl LTD is excited to announce a major transformation of its platform, shifting from a Chrome extension to a fully cloud-based web application. This upgrade brings seamless automation to Facebook and Instagram outreach, eliminating the need for users to keep their devices online while running powerful engagement campaigns effortlessly.

With this transition, the ReachOwl Chrome extension will become obsolete, and it will eventually be discontinued. Users can now take full advantage of the cloud-based platform, which offers far greater scalability, efficiency, and automation than the previous local processing method.

Game-Changing Automation for Facebook and Instagram Growth

ReachOwl's cloud-based system enables businesses, marketers, and agencies to execute large-scale outreach campaigns with ease. The new features include:

*
Direct messages to:

*
Members of specific Facebook groups (with or without admins)

*
Friends of a selected Facebook profile

*
Audiences engaging with Facebook ads and videos

*
Followers and followings of Instagram influencers

*
Custom profile lists for both Facebook and Instagram

* Friend and follow requests, with the ability to combine friend requests with DM campaigns for enhanced engagement.
*
Cloud-based account connection system, allowing users to connect multiple Facebook and Instagram accounts and manage all outreach from a single dashboard.

*
Keyword monitoring on Quora and Reddit, enabling users to track relevant discussions and engage in high-intent conversations.

*
Built-in CRM, providing a centralized database to view, filter, and export contacts, making it easier than ever to organize and scale outreach efforts.

*
Post scheduling for Facebook, allowing users to plan and automate posts across 100+ Facebook groups simultaneously.

Why This Update is a Game-Changer

Traditional outreach tools required users to keep their computers running and maintain an active connection to their social media accounts. With ReachOwl's cloud-based system, campaigns now run automatically-freeing users from manual efforts and making scaling outreach more efficient than ever.

" This update marks a significant milestone for ReachOwl and our users, " said Usama Noman, Founder of ReachOwl LTD. " By transitioning to a cloud-based platform, we're offering a faster, more scalable, and fully automated solution. Our Chrome extension will soon be phased out, as this new system provides a vastly superior experience. "

Built for Growth, Designed for Simplicity

ReachOwl's intuitive dashboard streamlines the entire outreach process, allowing users to:

*
Run multiple simultaneous DM campaigns with different targeting methods

*
Manage multiple Facebook and Instagram accounts under one platform

*
Track campaign performance and refine strategies with built-in analytics

*
Automate engagement and lead generation without manual intervention

About ReachOwl

ReachOwl LTD, based in the United Kingdom, is a cutting-edge social media automation platform designed to help businesses scale their outreach efforts effortlessly. The latest cloud-based transition allows users to maximize their social media presence while focusing on growth and engagement.

For more details, visit ReachOwl.com [https://reachowl.com/].

Connect with Usama Noman on LinkedIn: https://www.linkedin.com/in/usamanoman.

Media Contact
Company Name: ReachOwl
Contact Person: Usama Noman
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=reachowl-revolutionizes-facebook-and-instagram-outreach-with-cloudbased-automation]
Phone: +923443014737
State: London
Country: United Kingdom
Website: https://reachowl.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ReachOwl Revolutionizes Facebook and Instagram Outreach with Cloud-Based Automation here

News-ID: 3934189 • Views:

More Releases from ABNewswire

DHODH Inhibitor Pipeline Drugs Report 2025: Comprehensive Analysis of Drug Development, Clinical Trials, and Strategic Industry Outlook
DHODH Inhibitor Pipeline Drugs Report 2025: Comprehensive Analysis of Drug Devel …
DelveInsight's "DHODH Inhibitor Pipeline Insight 2025" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the DHODH Inhibitor pipeline landscape. It covers the DHODH Inhibitor pipeline drug profiles, including clinical and nonclinical stage products. It also covers the DHODH Inhibitor pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious about the latest updates
Peripheral Arterial Disease Pipeline Drugs Report 2025 by DelveInsight: Exploring Breakthrough Therapies and Advancements Shaping the Global Healthcare Landscape
Peripheral Arterial Disease Pipeline Drugs Report 2025 by DelveInsight: Explorin …
DelveInsight's "Peripheral Arterial Disease Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in the Peripheral Arterial Disease pipeline landscape. It covers the Peripheral Arterial Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Peripheral Arterial Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
Congenital Adrenal Hyperplasia Pipeline Drugs Report 2025: In-Depth Insights into Emerging Drugs, Clinical Developments, and Future Market Dynamics
Congenital Adrenal Hyperplasia Pipeline Drugs Report 2025: In-Depth Insights int …
DelveInsight's "Congenital Adrenal Hyperplasia Pipeline Insight 2025" report provides comprehensive insights about 5+ companies and 8+ pipeline drugs in the Congenital Adrenal Hyperplasia pipeline landscape. It covers the Congenital Adrenal Hyperplasia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Congenital Adrenal Hyperplasia pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Curious
UNT Health: Advancing Healthcare, Education, and Research in Fort Worth
UNT Health: Advancing Healthcare, Education, and Research in Fort Worth
As UNT Health continues to grow, it remains dedicated to its core mission: educating the next generation of healthcare leaders, delivering high-quality patient care, and advancing research that improves lives. With a strong foundation in academic excellence and a commitment to community well-being, UNT Health is shaping the future of healthcare in Fort Worth and setting a standard for integrated, patient-focused medical care. UNT Health, formerly known as HSC Fort Worth,

All 5 Releases